Literature DB >> 28437001

Tumour-associated changes in intestinal epithelial cells cause local accumulation of KLRG1+ GATA3+ regulatory T cells in mice.

Holger Meinicke1,2,3, Anna Bremser1,2, Maria Brack1,2, Paulina Akeus4, Claire Pearson5, Samuel Bullers5, Katrin Hoffmeyer1, Marc P Stemmler1, Marianne Quiding-Järbrink4, Ana Izcue1,2.   

Abstract

CD4+ Foxp3+ regulatory T (Treg) cells include differentiated populations of effector Treg cells characterized by the expression of specific transcription factors. Tumours, including intestinal malignancies, often present with local accumulation of Treg cells that can prevent tumour clearance, but how tumour progression leads to Treg cell accumulation is incompletely understood. Here using genetically modified mouse models we show that ablation of E-cadherin, a process associated with epithelial to mesenchymal transition and tumour progression, promotes the accumulation of intestinal Treg cells by the specific accumulation of the KLRG1+ GATA3+ Treg subset. Epithelial E-cadherin ablation activates the β-catenin pathway, and we find that increasing β-catenin signals in intestinal epithelial cells also boosts Treg cell frequencies through local accumulation of KLRG1+ GATA3+ Treg cells. Both E-cadherin ablation and increased β-catenin signals resulted in epithelial cells with higher levels of interleukin-33, a cytokine that preferentially expands KLRG1+ GATA3+ Treg cells. Tumours often present reduced E-cadherin expression and increased β-catenin signalling and interleukin-33 production. Accordingly, Treg cell accumulation in intestinal tumours from APCmin/+ mice was exclusively due to the increase in KLRG1+ GATA3+ Treg cells. Our data identify a novel axis through which epithelial cells control local Treg cell subsets, which may be activated during intestinal tumorigenesis.
© 2017 John Wiley & Sons Ltd.

Entities:  

Keywords:  cell surface molecules; mucosa; regulatory T cells; tumour immunology

Mesh:

Substances:

Year:  2017        PMID: 28437001      PMCID: PMC5543491          DOI: 10.1111/imm.12750

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  46 in total

Review 1.  Regulatory T cells in cancer immunotherapy.

Authors:  Hiroyoshi Nishikawa; Shimon Sakaguchi
Journal:  Curr Opin Immunol       Date:  2014-01-14       Impact factor: 7.486

2.  IL-33 activates tumor stroma to promote intestinal polyposis.

Authors:  Rebecca L Maywald; Stephanie K Doerner; Luca Pastorelli; Carlo De Salvo; Susan M Benton; Emily P Dawson; Denise G Lanza; Nathan A Berger; Sanford D Markowitz; Heinz-Josef Lenz; Joseph H Nadeau; Theresa T Pizarro; Jason D Heaney
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-27       Impact factor: 11.205

3.  Treg-cell depletion promotes chemokine production and accumulation of CXCR3(+) conventional T cells in intestinal tumors.

Authors:  Paulina Akeus; Veronica Langenes; Jonas Kristensen; Astrid von Mentzer; Tim Sparwasser; Sukanya Raghavan; Marianne Quiding-Järbrink
Journal:  Eur J Immunol       Date:  2015-04-14       Impact factor: 5.532

4.  Redundant sources of Wnt regulate intestinal stem cells and promote formation of Paneth cells.

Authors:  Henner F Farin; Johan H Van Es; Hans Clevers
Journal:  Gastroenterology       Date:  2012-08-23       Impact factor: 22.682

5.  Two FOXP3(+)CD4(+) T cell subpopulations distinctly control the prognosis of colorectal cancers.

Authors:  Takuro Saito; Hiroyoshi Nishikawa; Hisashi Wada; Yuji Nagano; Daisuke Sugiyama; Koji Atarashi; Yuka Maeda; Masahide Hamaguchi; Naganari Ohkura; Eiichi Sato; Hirotsugu Nagase; Junichi Nishimura; Hirofumi Yamamoto; Shuji Takiguchi; Takeshi Tanoue; Wataru Suda; Hidetoshi Morita; Masahira Hattori; Kenya Honda; Masaki Mori; Yuichiro Doki; Shimon Sakaguchi
Journal:  Nat Med       Date:  2016-04-25       Impact factor: 53.440

6.  Identification of stem cells in small intestine and colon by marker gene Lgr5.

Authors:  Nick Barker; Johan H van Es; Jeroen Kuipers; Pekka Kujala; Maaike van den Born; Miranda Cozijnsen; Andrea Haegebarth; Jeroen Korving; Harry Begthel; Peter J Peters; Hans Clevers
Journal:  Nature       Date:  2007-10-14       Impact factor: 49.962

7.  The alarmin IL-33 promotes regulatory T-cell function in the intestine.

Authors:  Chris Schiering; Thomas Krausgruber; Agnieszka Chomka; Anja Fröhlich; Krista Adelmann; Elizabeth A Wohlfert; Johanna Pott; Thibault Griseri; Julia Bollrath; Ahmed N Hegazy; Oliver J Harrison; Benjamin M J Owens; Max Löhning; Yasmine Belkaid; Padraic G Fallon; Fiona Powrie
Journal:  Nature       Date:  2014-07-16       Impact factor: 49.962

8.  A Distinct Function of Regulatory T Cells in Tissue Protection.

Authors:  Nicholas Arpaia; Jesse A Green; Bruno Moltedo; Aaron Arvey; Saskia Hemmers; Shaopeng Yuan; Piper M Treuting; Alexander Y Rudensky
Journal:  Cell       Date:  2015-08-27       Impact factor: 41.582

9.  Transcription factor Foxp3 and its protein partners form a complex regulatory network.

Authors:  Dipayan Rudra; Paul deRoos; Ashutosh Chaudhry; Rachel E Niec; Aaron Arvey; Robert M Samstein; Christina Leslie; Scott A Shaffer; David R Goodlett; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2012-08-26       Impact factor: 25.606

10.  Developmental stage, phenotype, and migration distinguish naive- and effector/memory-like CD4+ regulatory T cells.

Authors:  Jochen Huehn; Kerstin Siegmund; Joachim C U Lehmann; Christiane Siewert; Uta Haubold; Markus Feuerer; Gudrun F Debes; Joerg Lauber; Oliver Frey; Grzegorz K Przybylski; Uwe Niesner; Maurus de la Rosa; Christian A Schmidt; Rolf Bräuer; Jan Buer; Alexander Scheffold; Alf Hamann
Journal:  J Exp Med       Date:  2004-02-02       Impact factor: 14.307

View more
  10 in total

Review 1.  Reciprocal Interactions Between Regulatory T Cells and Intestinal Epithelial Cells.

Authors:  Zhiqiang Jiang; Chuan Wu
Journal:  Front Immunol       Date:  2022-07-04       Impact factor: 8.786

Review 2.  The Yin and Yang of Targeting KLRG1+ Tregs and Effector Cells.

Authors:  Samantha M Borys; Arup K Bag; Laurent Brossay; Dennis O Adeegbe
Journal:  Front Immunol       Date:  2022-04-29       Impact factor: 8.786

3.  Epithelial-derived IL-33 promotes intestinal tumorigenesis in Apc Min/+ mice.

Authors:  Zhengxiang He; Lili Chen; Fabricio O Souto; Claudia Canasto-Chibuque; Gerold Bongers; Madhura Deshpande; Noam Harpaz; Huaibin M Ko; Kevin Kelley; Glaucia C Furtado; Sergio A Lira
Journal:  Sci Rep       Date:  2017-07-14       Impact factor: 4.379

Review 4.  IL33 and Mast Cells-The Key Regulators of Immune Responses in Gastrointestinal Cancers?

Authors:  Moritz F Eissmann; Michael Buchert; Matthias Ernst
Journal:  Front Immunol       Date:  2020-07-03       Impact factor: 7.561

Review 5.  The Pro-tumorigenic IL-33 Involved in Antitumor Immunity: A Yin and Yang Cytokine.

Authors:  Jean-Jacques Fournié; Mary Poupot
Journal:  Front Immunol       Date:  2018-10-26       Impact factor: 7.561

Review 6.  Interleukin-33 in Malignancies: Friends or Foes?

Authors:  Jia-Xin Shen; Jing Liu; Guo-Jun Zhang
Journal:  Front Immunol       Date:  2018-12-20       Impact factor: 7.561

7.  Effector T cell responses unleashed by regulatory T cell ablation exacerbate oral squamous cell carcinoma.

Authors:  Jaime L Chao; Michael Korzinkin; Alex Zhavoronkov; Ivan V Ozerov; Matthew T Walker; Kathleen Higgins; Mark W Lingen; Evgeny Izumchenko; Peter A Savage
Journal:  Cell Rep Med       Date:  2021-09-14

Review 8.  Innate lymphoid cells in colorectal cancer.

Authors:  Anne Marchalot; Jenny Mjösberg
Journal:  Scand J Immunol       Date:  2022-03-16       Impact factor: 3.889

Review 9.  The Pleiotropic Immunomodulatory Functions of IL-33 and Its Implications in Tumor Immunity.

Authors:  Claudia Afferni; Carla Buccione; Sara Andreone; Maria Rosaria Galdiero; Gilda Varricchi; Gianni Marone; Fabrizio Mattei; Giovanna Schiavoni
Journal:  Front Immunol       Date:  2018-11-13       Impact factor: 7.561

Review 10.  The ST2/Interleukin-33 Axis in Hematologic Malignancies: The IL-33 Paradox.

Authors:  Alessandro Allegra; Vanessa Innao; Gennaro Tartarisco; Giovanni Pioggia; Marco Casciaro; Caterina Musolino; Sebastiano Gangemi
Journal:  Int J Mol Sci       Date:  2019-10-22       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.